Akoya Biosciences, Inc.

NASDAQ:AKYA

2.49 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -10.533-13.149-23.484-10.802-12.916-20.803-18.802-18.875-17.872-17.495-16.399-17.673-11.617-5.563-8.082-5.694-4.284-4.585-2.143
Depreciation & Amortization 1.8251.9262.0512.1062.5762.0872.1211.9011.9391.691.6191.3741.2441.1331.0411.0230.9710.9220.899
Deferred Income Tax 0.03800.037-0.051-2.1982.1930-0.06400.0890.01-0.119-0.02-0.006-0.01-0.041-0.0110.0320.027
Stock Based Compensation 1.8812.7132.5662.5642.8782.622.3752.122.0441.7211.5451.4111.1581.2160.2540.0540.060.0510.312
Change In Working Capital 12.003-3.788-8.215-0.452-7.7630.227-5.8524.2481.2411.687-5.0128.022-4.491-8.083-0.009-0.2760.5880.7551.327
Accounts Receivables 3.768-3.6213.146-0.898-3.230.077-3.214-1.0491.7920.842-1.870.161-1.447-1.568-0.12-0.945-1.5062.5226.626
Change In Inventory -0.782-2.287-7.310.708-2.995-3.908-0.137-1.3980.155-1.845-2.286-2.3560.267-2.109-0.43-0.408-0.3871.018-0.907
Change In Accounts Payables -1.025-0.962-1.029-0.1140.1583.049-1.9452.456-5.21.8542.0835.364-0.827-0.8780.7021.0052.382-1.753-4.679
Other Working Capital 10.0423.082-3.022-0.148-1.6961.009-0.5564.2394.4940.836-2.9394.853-2.484-3.528-0.1610.0720.099-1.0320.287
Other Non Cash Items -14.471.25718.0821.0843.671.8720.40.6630.477-1.0780.3051.1310.331-1.1122.4022.7870.9360.826-1.379
Operating Cash Flow -9.256-11.041-20.824-5.551-13.753-11.804-19.758-10.007-12.171-13.386-17.932-5.854-13.395-12.415-4.404-2.147-1.74-1.999-0.957
Investing Activities:
Investments In Property Plant And Equipment -0.434-0.17-0.81-0.594-0.832-1.423-0.804-0.869-3.789-1.564-1.138-1.365-1.875-0.947-0.907-0.487-0.862-0.55-1.396
Acquisitions Net 00000000.05500000000000
Purchases Of Investments -17.545-21.776-48.0070000-23.0550-40.774000000000
Sales Maturities Of Investments 30.99831000072311.0550000000000
Other Investing Activites 00-48.00700072311.055-40.7740000010.14-0.04-0.038-0.039
Investing Cash Flow 13.0199.054-48.817-0.594-0.832-1.4236.19622.1317.266-42.338-1.138-1.365-1.875-0.947-0.9079.653-0.902-0.588-1.435
Financing Activities:
Debt Repayment -0.166-0.173-0.18111.07-0.175-0.173-0.14811.0879.8589.81-0.126-0.072-0.074-0.128-0.0487.451-0.0482.417-0.035
Common Stock Issued -0.0590.0230.036-0.028-0.07648.2140.0580.1880.040.1640.0550.2210.03138.6520.0440000
Common Stock Repurchased 0.214-0.065-0.1490.09400-0.094000000000000
Dividends Paid 00000000000-1.43500-1.190000
Other Financing Activities 0.016-1.952-0.2630.0350.03446.5-0.271-0.8170.002-1.1430.0550.2210.03137.0620.044-1.7640.0880.002-2.625
Financing Cash Flow -0.15-2.125-0.44411.044-0.14146.327-0.41910.279.868.667-0.0710.149-0.044136.934-0.0045.6870.042.419-2.66
Other Information:
Effect Of Forex Changes On Cash 000-0.369-1.3310000005.6350000000
Net Change In Cash 3.613-4.112-70.0864.53-14.72633.1-13.98122.3944.955-47.057-19.141-7.07-15.314123.572-5.31513.193-2.602-0.168-5.052
Cash At End Of Period 13.249.62713.03983.12578.92593.65160.55174.53252.13847.18394.24113.381120.451135.76512.19317.5084.3156.9177.085